(Q39479222)

12 September 2017

Treatment of neurotoxic side effects of interferon-alpha with naltrexone (English)

1 reference

12 September 2017

0 references

1 reference

Valentine AD

1

1 reference

PubMed ID

7583704

12 September 2017

Meyers CA

series ordinal

2

1 reference

PubMed ID

7583704

12 September 2017

Talpaz M

series ordinal

3

1 reference

12 September 2017

1 January 1995

1 reference

12 September 2017

1 reference

12 September 2017

13

1 reference

12 September 2017

561-566

1 reference

12 September 2017

6

1 reference

Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer.

12 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Psychiatric complications of long-term interferon alfa therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Behavioral assessment of patients treated with alpha-interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Central nervous system toxicity of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Persistent neurotoxicity of systemically administered interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Naloxone blocks the interferon-alpha induced changes in hypothalamic neuronal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Alpha-interferon modifies cortical EEG activity: dose-dependence and antagonism by naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Does the immune system communicate with the central nervous system? Interferon modifies central nervous activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Single injection of three different preparations of alpha-interferon modifies morphine abstinence signs for a prolonged period.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Cerebral interferon entry in mice after osmotic alteration of blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

Does interferon exert its actions through opiate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509024923

10.3109/07357909509024923

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

7583704